A detailed history of Clark Capital Management Group, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 182,288 shares of UTHR stock, worth $66.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
182,288
Previous 175,913 3.62%
Holding current value
$66.3 Million
Previous $56 Million 16.57%
% of portfolio
0.46%
Previous 0.42%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $1.98 Million - $2.32 Million
6,375 Added 3.62%
182,288 $65.3 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $14 Million - $19.6 Million
61,318 Added 53.51%
175,913 $56 Million
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $636,495 - $753,520
3,020 Added 2.71%
114,595 $26.3 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $4.32 Million - $5.17 Million
-20,120 Reduced 15.28%
111,575 $24.5 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $6.72 Million - $7.87 Million
31,721 Added 31.73%
131,695 $29.7 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $245,407 - $278,656
1,196 Added 1.21%
99,974 $22.1 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $569,535 - $738,478
2,674 Added 2.78%
98,778 $22.1 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $17.2 Million - $23.4 Million
83,425 Added 657.98%
96,104 $26.7 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $42,489 - $51,031
209 Added 1.68%
12,679 $2.66 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $1,398 - $1,929
-8 Reduced 0.06%
12,470 $2.94 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $1.01 Million - $1.3 Million
-6,079 Reduced 32.76%
12,478 $2.24 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $140,820 - $165,085
-764 Reduced 3.95%
18,557 $4.01 Million
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $143,708 - $171,689
799 Added 4.31%
19,321 $3.57 Million
Q2 2021

Aug 02, 2021

BUY
$170.47 - $211.93 $441,858 - $549,322
2,592 Added 16.27%
18,522 $3.32 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $1.16 Million - $1.31 Million
-7,511 Reduced 32.04%
15,930 $2.67 Million
Q4 2020

Jan 26, 2021

BUY
$101.87 - $151.79 $2.39 Million - $3.56 Million
23,441 New
23,441 $3.56 Million
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $2.55 Million - $3.09 Million
-25,510 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $754,625 - $1.02 Million
-8,137 Reduced 24.18%
25,510 $3.09 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $587,644 - $853,820
7,402 Added 28.2%
33,647 $3.19 Million
Q4 2019

Jan 27, 2020

BUY
$78.31 - $95.34 $2.06 Million - $2.5 Million
26,245 New
26,245 $2.31 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.